Back

Liver function tests in patients receiving high-intensity care after hospital admission for acute heart failure: the STRONG-HF trial

30 August 2024 (09:27 - 09:45)
Organised by: Logo
Congress Presentation Part of: Biomarkers to guide the treatment of heart failure: where are we going? Treatment ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Professor Peder Langeland Myhre

Oslo University Hospital Rikshospitalet, Oslo (Norway)

4 More presentations in this session

Presentation thumbnail
State-of-the-art lecture on biomarkers to guide the treatment of heart failure: where are we going?
Professor J. Januzzi (Boston, US)
Slides Video
Presentation thumbnail
Outcomes and effects of sacubitril/valsartan according to NT-proBNP level in patients with heart failure: a patient-level pooled analysis of the PARADIGM-HF and PARAGON-HF trials
Doctor T. Kondo (Nagoya, JP)
Abstract Slides Video
Presentation thumbnail
Urinary proteomic signature of mineralocorticoid receptor antagonism by spironolactone: evidence from the HOMAGE trial
Doctor Y. Yu (Leuven, BE)
Abstract Slides Video
Presentation thumbnail
Heart failure and renal outcomes in patient treated with GLP1 agonists.
Doctor N. del-Cuerpo-Salinas (Sant Joan d'Alacant, ES)
Abstract Slides Video

Access the full session

Session thumbnail
Biomarkers to guide the treatment of heart failure: where are we going?
Video

The Event

Event poster

ESC Congress 2024

30 August 2024 09:27 CET
You may be interested in
thumbnail
Congress Session
Biomarkers to guide the treatment of heart failure: where are we going?
thumbnail
Congress Presentation
Strategies to improve implementation of evidence-based heart failure treatments - Overcoming clinical inertia
thumbnail
Congress Session
Novel biomarkers in heart failure

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources